EUVIMEDObjevte EUVIMED
Crossref

Intracochlear Drug Delivery Using a Catheter and Dexamethasone‐Eluting Electrode Preserves Residual Hearing Post‐Cochlear Implantation

Maria-Pia Tuset, Jaimee N Cooper, Dario Ebode, Jeenu Mittal, Carolyn Garnham, Teresa Melchionna, Roland Hessler, Sören Schilp, Dimitri Godur, Keelin McKenna, Rahul Mittal, Adrien A Eshraghi

Otolaryngology–Head and Neck Surgery · 2025

DOI: 10.1002/ohn.1252 ↗

At a glance

Journal article in Otolaryngology–Head and Neck Surgery, 2025. Written by Maria-Pia Tuset and 11 co-authors. Institution: Department of Otolaryngology, Hearing Research and Cochlear Implant Laboratory, University of Miami Miller School of Medicine, Miami, Florida, USA. Major MEDLINE topics: Dexamethasone, Cochlear Implantation, Cochlear Implants, Drug Delivery Systems. Cited 5 times so far (Crossref); 45 references. Funded by: MED-EL GmBh.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objectives

This study aims to assess the feasibility and safety of a cochlear catheter (cannula) for inner ear drug delivery during cochlear implantation. We evaluated the otoprotective effect of L‐N‐acetylcysteine (L‐NAC) administered via a cannula in combination with a dexamethasone‐eluting cochlear implant (CI). Study Design An animal model study.

Setting

Animal facility of an academic institution.

Methods

Animals were divided into 8 groups: (1) implantation with a CI; (2) implantation with a dexamethasone‐eluting CI (CIDexel); (3) cannula injection of artificial perilymph (Can+AP); (4) cannula injection of Ringer (Can+R); (5) cannula injection of R and CI (Can+CI); (6) cannula injection of R and Dexel (Can+Dexel); (7) cannula injection of 2 mM L‐NAC and CI (Can L‐NAC 2 mM+CI); or (8) cannula injection of 2mM L‐NAC and Dexel (Can L‐NAC 2 mM++Dexel). The contralateral ear served as the control group. Hearing thresholds were determined preoperatively, and at postoperative day (POD 7) and POD 30 post‐cochlear implantation, using auditory brainstem responses (ABRs). The organ of Corti dissections were performed at POD 30 for hair cell (HC) viability, and oxidative stress assessment using immunostaining.

Results

The L‐NAC (2 mM) and dexamethasone‐eluting electrode group had significantly lower hearing thresholds than the standard CI, Can L‐NAC 2 mM, and Dexel groups. The animal group treated with L‐NAC (2 mM) and dexamethasone‐eluting electrode showed higher HC viability and reduced oxidative stress.

Conclusion

An intracochlear cannula can deliver pharmaceutical interventions without causing additional hearing loss. L‐NAC presents strong anti‐apoptotic potential and administration through a cannula together with Dexel implantation, and achieves a synergistic effect enhancing the otoprotection.

Subjects

MeSH terms (MEDLINE)

DexamethasoneCochlear ImplantationCochlear ImplantsDrug Delivery SystemsAcetylcysteineCathetersHearingAnimalsCochleaEvoked Potentials, Auditory, Brain StemDisease Models, AnimalFeasibility StudiesElectrodes, Implanted

Author keywords

L‐N‐acetylcysteinecochlear implantdexamethasonehearing preservationintracochlear catheterlocal drug deliveryotoprotection

Substances

DexamethasoneAcetylcysteine

Authors and institutions

  • Department of Otolaryngology, Hearing Research and Cochlear Implant Laboratory, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • MED-El GmBh, Innsbruck, Austria.
  • Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Department of Biomedical Engineering, University of Miami, Coral Gables, Florida, USA.
  • Department of Pediatrics, University of Miami Miller School of Medicine, Miami, Florida, USA.

Funding

  • MED-EL GmBh

Cite

APA

Tuset, M. P., Cooper, J. N., Ebode, D., Mittal, J., Garnham, C., Melchionna, T., Hessler, R., Schilp, S., Godur, D., McKenna, K., Mittal, R., & Eshraghi, A. A. (2025). Intracochlear Drug Delivery Using a Catheter and Dexamethasone‐Eluting Electrode Preserves Residual Hearing Post‐Cochlear Implantation. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.1252

Vancouver

Tuset MP, Cooper JN, Ebode D, Mittal J, Garnham C, Melchionna T, et al. Intracochlear Drug Delivery Using a Catheter and Dexamethasone‐Eluting Electrode Preserves Residual Hearing Post‐Cochlear Implantation. Otolaryngology–Head and Neck Surgery. 2025. doi:10.1002/ohn.1252

BibTeX
@article{Tuset2025,
  author = {Tuset, Maria-Pia and Cooper, Jaimee N and Ebode, Dario and Mittal, Jeenu and Garnham, Carolyn and Melchionna, Teresa and Hessler, Roland and Schilp, Sören and Godur, Dimitri and McKenna, Keelin and Mittal, Rahul and Eshraghi, Adrien A},
  title = {Intracochlear Drug Delivery Using a Catheter and Dexamethasone‐Eluting Electrode Preserves Residual Hearing Post‐Cochlear Implantation},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2025},
  doi = {10.1002/ohn.1252}
}
Start for free →